Heme oxygenase-1 is a potent inhibitor of placental ischemia-mediated endothelin-1 production in cultured human glomerular endothelial cells

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 314, Issue 3, 2018, Pages R427-R432

  Bakrania, Bhavisha A ^a   Spradley, Frank T ^a   Satchell, Simon C ^b   Stec, David E ^a   Rimoldi, John M ^c   Gadepalli, Rama S V ^c   Granger, Joey P ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

^c UNIVERSITY OF MISSISSIPPI   (United States)

Author keywords

Bilirubin; Inflammation; Kidney; Preeclampsia; Women's health

Indexed keywords

BILIRUBIN; BILIVERDIN; BORANE DERIVATIVE; CARBONIC ACID; ENDOTHELIN 1; HEME OXYGENASE 1; HMOX1 PROTEIN, HUMAN; PROTOPORPHYRIN; PROTOPORPHYRIN COBALT; SODIUM BORANOCARBONATE; TUMOR NECROSIS FACTOR;

ANIMAL; ARTERIAL PRESSURE; BLOOD; CELL CULTURE; DISEASE MODEL; DRUG EFFECT; ENDOTHELIUM CELL; ENZYME INDUCTION; ENZYMOLOGY; FEMALE; GLOMERULUS; ISCHEMIA; METABOLISM; PATHOPHYSIOLOGY; PLACENTA; PLACENTA CIRCULATION; PREECLAMPSIA; PREGNANCY; SPRAGUE DAWLEY RAT; VASCULARIZATION;

ANIMALS; ARTERIAL PRESSURE; BILIRUBIN; BILIVERDINE; BORANES; CARBONATES; CELLS, CULTURED; DISEASE MODELS, ANIMAL; ENDOTHELIAL CELLS; ENDOTHELIN-1; ENZYME INDUCTION; FEMALE; HEME OXYGENASE-1; ISCHEMIA; KIDNEY GLOMERULUS; PLACENTA; PLACENTAL CIRCULATION; PRE-ECLAMPSIA; PREGNANCY; PROTOPORPHYRINS; RATS, SPRAGUE-DAWLEY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 85048253815     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/AJPREGU.00370.2017     Document Type: Article

References (56)

1. Ahmed A, Rahman M, Zhang X, Acevedo CH, Nijjar S, Rushton I, Bussolati B, St John J. Induction of placental heme oxygenase-1 is protective against TNFalpha-induced cytotoxicity and promotes vessel relaxation. Mol Med 6: 391-409, 2000.
2. Alexander BT. Placental insufficiency leads to development of hypertension in growth-restricted offspring. Hypertension 41: 457-462, 2003. doi:10.1161/01.HYP.0000053448.95913.3D.
3. Bakrania B, Du Toit EF, Wagner K-H, Headrick JP, Bulmer AC. Preor post-ischemic bilirubin ditaurate treatment reduces oxidative tissue damage and improves cardiac function. Int J Cardiol 202: 27-33, 2016. doi:10.1016/j.ijcard.2015.08.192.
4. Bellamy L, Casas J-P, Hingorani AD, Williams DJ. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. BMJ 335: 974, 2007. doi:10.1136/bmj. 39335.385301.BE.
5. Bisht K, Wegiel B, Tampe J, Neubauer O, Wagner K-H, Otterbein LE, Bulmer AC. Biliverdin modulates the expression of C5aR in response to endotoxin in part via mTOR signaling. Biochem Biophys Res Commun 449: 94-99, 2014. doi:10.1016/j.bbrc.2014.04.150.
6. Collino F, Bussolati B, Gerbaudo E, Marozio L, Pelissetto S, Benedetto C, Camussi G. Preeclamptic sera induce nephrin shedding from podocytes through endothelin-1 release by endothelial glomerular cells. Am J Physiol Renal Physiol 294: F1185-F1194, 2008. doi:10.1152/ ajprenal.00442.2007.
7. Craici IM, Wagner SJ, Weissgerber TL, Grande JP, Garovic VD. Advances in the pathophysiology of pre-eclampsia and related podocyte injury. Kidney Int 86: 275-285, 2014. doi:10.1038/ki.2014.17.
8. Cudmore M, Ahmad S, Al-Ani B, Fujisawa T, Coxall H, Chudasama K, Devey LR, Wigmore SJ, Abbas A, Hewett PW, Ahmed A. Negative regulation of soluble Flt-1 and soluble endoglin release by heme oxygenase-1. Circulation 115: 1789-1797, 2007. doi:10.1161/CIRCULATIONAHA.106. 660134.
9. Freeman DJ, McManus F, Brown EA, Cherry L, Norrie J, Ramsay JE, Clark P, Walker ID, Sattar N, Greer IA. Short- and long-term changes in plasma inflammatory markers associated with preeclampsia. Hypertension 44: 708-714, 2004. doi:10.1161/01.HYP.0000143849. 67254.ca.
10. George EM, Cockrell K, Aranay M, Csongradi E, Stec DE, Granger JP. Induction of heme oxygenase 1 attenuates placental ischemia-induced hypertension. Hypertension 57: 941-948, 2011. doi:10.1161/HYPERTENSIONAHA. 111.169755.
11. George EM, Cockrell K, Arany M, Stec DE, Rimoldi JM, Gadepalli RSV, Granger JP. Carbon monoxide releasing molecules blunt placental ischemia-induced hypertension. Am J Hypertens 30: 931-937, 2017. doi:10.1093/ajh/hpx070.
12. George EM, Colson D, Dixon J, Palei AC, Granger JP. Heme oxygenase- 1 attenuates hypoxia-induced sFlt-1 and oxidative stress in placental villi through its metabolic products CO and bilirubin. Int J Hypertens 2012: 486053, 2012. doi:10.1155/2012/486053.
13. George EM, Warrington JP, Spradley FT, Palei AC, Granger JP. The heme oxygenases: important regulators of pregnancy and preeclampsia. Am J Physiol Regul Integr Comp Physiol 307: R769-R777, 2014. doi:10. 1152/ajpregu.00132.2014.
14. Gilbert JS, Ryan MJ, LaMarca BB, Sedeek M, Murphy SR, Granger JP. Pathophysiology of hypertension during preeclampsia: linking placental ischemia with endothelial dysfunction. Am J Physiol Heart Circ Physiol 294: H541-H550, 2008. doi:10.1152/ajpheart.01113.2007.
15. Gruslin A, Lemyre B. Pre-eclampsia: fetal assessment and neonatal outcomes. Best Pract Res Clin Obstet Gynaecol 25: 491-507, 2011. doi:10.1016/j.bpobgyn.2011.02.004.
16. Guo P, Qi X, Yuan R, Li H, Gao X, Wang J, Zhang B. Tet1-mediated DNA demethylation involves in neuron damage induced by bilirubin in vitro. Toxicol Mech Methods 25: 1-7, 2007. doi:10.1080/15376516.2017. 1357775.
17. Ikeda Y, Hamano H, Satoh A, Horinouchi Y, Izawa-Ishizawa Y, Kihira Y, Ishizawa K, Aihara K, Tsuchiya K, Tamaki T. Bilirubin exerts pro-angiogenic property through Akt-eNOS-dependent pathway. Hypertens Res 38: 733-740, 2015. doi:10.1038/hr.2015.74.
18. Jain A. Endothelin-1: a key pathological factor in pre-eclampsia? Reprod Biomed Online 25: 443-449, 2012. doi:10.1016/j.rbmo.2012.07.014.
19. Jansen T, Hortmann M, Oelze M, Opitz B, Steven S, Schell R, Knorr M, Karbach S, Schuhmacher S, Wenzel P, Münzel T, Daiber A. Conversion of biliverdin to bilirubin by biliverdin reductase contributes to endothelial cell protection by heme oxygenase-1-evidence for direct and indirect antioxidant actions of bilirubin. J Mol Cell Cardiol 49: 186-195, 2010. doi:10.1016/j.yjmcc.2010.04.011.
20. Khan KS, Wojdyla D, Say L, Gülmezoglu AM, Van Look PF. WHO analysis of causes of maternal death: a systematic review. Lancet 367: 1066-1074, 2006. doi:10.1016/S0140-6736(06)68397-9.
21. LaMarca BD, Ryan MJ, Gilbert JS, Murphy SR, Granger JP. Inflammatory cytokines in the pathophysiology of hypertension during preeclampsia. Curr Hypertens Rep 9: 480-485, 2007. doi:10.1007/s11906-007-0088-1.
22. LaMarca B, Speed J, Fournier L, Babcock SA, Berry H, Cockrell K, Granger JP. Hypertension in response to chronic reductions in uterine perfusion in pregnant rats: effect of tumor necrosis factor-alpha blockade. Hypertension 52: 1161-1167, 2008. doi:10.1161/HYPERTENSIONAHA. 108.120881.
23. LaMarca BB, Bennett WA, Alexander BT, Cockrell K, Granger JP. Hypertension produced by reductions in uterine perfusion in the pregnant rat: role of tumor necrosis factor-alpha. Hypertension 46: 1022-1025, 2005. doi:10.1161/01.HYP.0000175476.26719.36.
24. Lau SY, Guild SJ, Barrett CJ, Chen Q, McCowan L, Jordan V, Chamley LW. Tumor necrosis factor-alpha, interleukin-6, and interleukin- 10 levels are altered in preeclampsia: a systematic review and metaanalysis. Am J Reprod Immunol 70: 412-427, 2013.
25. Levytska K, Kingdom J, Baczyk D, Drewlo S. Heme oxygenase-1 in placental development and pathology. Placenta 34: 291-298, 2013. doi: 10.1016/j.placenta.2013.01.004.
26. Li J, LaMarca B, Reckelhoff JF. A model of preeclampsia in rats: the reduced uterine perfusion pressure (RUPP) model. Am J Physiol Heart Circ Physiol 303: H1-H8, 2012. doi:10.1152/ajpheart.00117.2012.
27. Liu XM, Peyton KJ, Durante W. Ammonia promotes endothelial cell survival via the heme oxygenase-1-mediated release of carbon monoxide. Free Radic Biol Med 102: 37-46, 2017. doi:10.1016/j.freeradbiomed. 2016.11.029.
28. Mazzone GL, Rigato I, Tiribelli C. Unconjugated bilirubin modulates nitric oxide production via iNOS regulation. Biosci Trends 4: 244-248, 2010.
29. Melchiorre K, Sutherland GR, Liberati M, Thilaganathan B. Preeclampsia is associated with persistent postpartum cardiovascular impairment. Hypertension 58: 709-715, 2011. doi:10.1161/HYPERTENSIONAHA.111. 176537.
30. Morita T, Kourembanas S. Endothelial cell expression of vasoconstrictors and growth factors is regulated by smooth muscle cell-derived carbon monoxide. J Clin Invest 96: 2676-2682, 1995. doi:10.1172/JCI118334.
31. Motterlini R, Sawle P, Hammad J, Bains S, Alberto R, Foresti R, Green CJ. CORM-A1: a new pharmacologically active carbon monoxidereleasing molecule. FASEB J 19: 284-286, 2005. doi:10.1096/fj.04-2169fje.
32. Ollinger R, Bilban M, Erat A, Froio A, McDaid J, Tyagi S, Csizmadia E, Graça-Souza AV, Liloia A, Soares MP, Otterbein LE, Usheva A, Yamashita K, Bach FH. Bilirubin: a natural inhibitor of vascular smooth muscle cell proliferation. Circulation 112: 1030-1039, 2005. doi:10.1161/ CIRCULATIONAHA.104.528802.
33. Otterbein LE, Soares MP, Yamashita K, Bach FH. Heme oxygenase-1: unleashing the protective properties of heme. Trends Immunol 24: 449-455, 2003. doi:10.1016/S1471-4906(03)00181-9.
34. Paauw ND, Joles JA, Spradley FT, Bakrania B, Zsengeller ZK, Franx A, Verhaar MC, Granger JP, Lely AT. Exposure to placental ischemia impairs postpartum maternal renal and cardiac function in rats. Am J Physiol Regul Integr Comp Physiol 312: R664-R670, 2017. doi:10.1152/ ajpregu.00510.2016.
35. Pollock JS, Pollock DM. Endothelin, nitric oxide, and reactive oxygen species in diabetic kidney disease. Contrib Nephrol 172: 149-159, 2011. doi:10.1159/000329054.
36. Powe CE, Levine RJ, Karumanchi SA. Preeclampsia, a disease of the maternal endothelium: the role of antiangiogenic factors and implications for later cardiovascular disease. Circulation 123: 2856-2869, 2011. doi: 10.1161/CIRCULATIONAHA.109.853127.
37. Roberts JM, August PA, Bakris G, Barton JR, Bernstein IM, Druzin M, Gaiser RR, Granger JP, Jeyabalan A, Johnson DD, Karumanchi S, Lindheimer M, Owens MY, Saade GR, Sibai BM, Spong CY, Tsigas E, Joseph GF, O'Reilly N, Politzer A, Son S, Ngaiza K. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists' Task Force on Hypertension in Pregnancy. Obstet Gynecol 122: 1122-1131, 2013. doi:10.1097/01.AOG.0000437382.03963.88.
38. Roberts JM, Escudero C. The placenta in preeclampsia. Pregnancy Hypertens 2: 72-83, 2012. doi:10.1016/j.preghy.2012.01.001.
39. Ryter SW, Alam J, Choi AMK. Heme oxygenase-1/carbon monoxide: from basic science to therapeutic applications. Physiol Rev 86: 583-650, 2006. doi:10.1152/physrev.00011.2005.
40. Satchell SC, Tasman CH, Singh A, Ni L, Geelen J, von Ruhland CJ, O'Hare MJ, Saleem MA, van den Heuvel LP, Mathieson PW. Conditionally immortalized human glomerular endothelial cells expressing fenestrations in response to VEGF. Kidney Int 69: 1633-1640, 2006. doi:10. 1038/sj.ki.5000277.
41. Schmidt HHHW. NO, CO, and OH. Endogenous soluble guanylyl cyclase- activating factors. FEBS Lett 307: 102-107, 1992. doi:10.1016/ 0014-5793(92)80910-9.
42. Spradley FT, Palei AC, Granger JP. Obese melanocortin-4 receptordeficient rats exhibit augmented angiogenic balance and vasorelaxation during pregnancy. Physiol Rep 1: e00081, 2013. doi:10.1002/phy2.81.
43. Stocker R, Yamamoto Y, McDonagh AF, Glazer AN, Ames BN. Bilirubin is an antioxidant of possible physiological importance. Science 235: 1043-1046, 1987.
44. Stocker R. Antioxidant activities of bile pigments. Antioxid Redox Signal 6: 841-849, 2004. doi:10.1089/ars.2004.6.841.
45. Sung LC, Chao HH, Chen CH, Tsai JC, Liu JC, Hong HJ, Cheng TH, Chen JJ. Lycopene inhibits cyclic strain-induced endothelin-1 expression through the suppression of reactive oxygen species generation and induction of heme oxygenase-1 in human umbilical vein endothelial cells. Clin Exp Pharmacol Physiol 42: 632-639, 2015. doi:10.1111/1440-1681. 12412.
46. Szarka A, Rigó J Jr, Lázár L, Beko G, Molvarec A. Circulating cytokines, chemokines and adhesion molecules in normal pregnancy and preeclampsia determined by multiplex suspension array. BMC Immunol 11: 59, 2010. doi:10.1186/1471-2172-11-59.
47. Tam Tam KB, George E, Cockrell K, Arany M, Speed J, Martin JN Jr, Lamarca B, Granger JP. Endothelin type A receptor antagonist attenuates placental ischemia-induced hypertension and uterine vascular resistance. Am J Obstet Gynecol 204: 330.e1-330.e4, 2011. doi:10.1016/ j.ajog.2011.01.049.
48. Urquhart P, Rosignoli G, Cooper D, Motterlini R, Perretti M. Carbon monoxide-releasing molecules modulate leukocyte-endothelial interactions under flow. J Pharmacol Exp Ther 321: 656-662, 2007. doi:10. 1124/jpet.106.117218.
49. Venditti CC, Casselman R, Young I, Karumanchi SA, Smith GN. Carbon monoxide prevents hypertension and proteinuria in an adenovirus sFlt-1 preeclampsia-like mouse model. PLoS One 9: e106502, 2014. doi:10.1371/journal.pone.0106502.
50. Venditti CC, Smith GN. Involvement of the heme oxygenase system in the development of preeclampsia and as a possible therapeutic target. Womens Health (Lond) 10: 623-643, 2014. doi:10.2217/WHE.14.54.
51. Verdonk K, Saleh L, Lankhorst S, Smilde JEI, van Ingen MM, Garrelds IM, Friesema ECH, Russcher H, van den Meiracker AH, Visser W, Danser AHJ. Association studies suggest a key role for endothelin-1 in the pathogenesis of preeclampsia and the accompanying renin-angiotensin-aldosterone system suppression. Hypertension 65: 1316-1323, 2015. doi:10.1161/HYPERTENSIONAHA.115.05267.
52. Volti GL, Sacerdoti D, Sangras B, Vanella A, Mezentsev A, Scapagnini G, Falck JR, Abraham NG. Carbon monoxide signaling in promoting angiogenesis in human microvessel endothelial cells. Antioxid Redox Signal 7: 704-710, 2005. doi:10.1089/ars.2005.7.704.
53. Warrington JP, Coleman K, Skaggs C, Hosick PA, George EM, Stec DE, Ryan MJ, Granger JP, Drummond HA. Heme oxygenase-1 promotes migration and -epithelial Na+ channel expression in cytotrophoblasts and ischemic placentas. Am J Physiol Regul Integr Comp Physiol 306: R641-R646, 2014. doi:10.1152/ajpregu.00566.2013.
54. Wegiel B, Gallo D, Csizmadia E, Roger T, Kaczmarek E, Harris C, Zuckerbraun BS, Otterbein LE. Biliverdin inhibits Toll-like receptor-4 (TLR4) expression through nitric oxide-dependent nuclear translocation of biliverdin reductase. Proc Natl Acad Sci USA 108: 18849-18854, 2011. doi:10.1073/pnas.1108571108.
55. Wegiel B, Otterbein LE. Go green: the anti-inflammatory effects of biliverdin reductase. Front Pharmacol 3: 47, 2012. doi:10.3389/fphar. 2012.00047.
56. Young SC, Storm MV, Speed JS, Kelsen S, Tiller CV, Vera T, Drummond HA, Stec DE. Inhibition of biliverdin reductase increases ANG II-dependent superoxide levels in cultured renal tubular epithelial cells. Am J Physiol Regul Integr Comp Physiol 297: R1546-R1553, 2009. doi:10.1152/ajpregu.90933.2008.